Oliver Sol

Hoofd Techniek/Wetenschap/O&O bij AC IMMUNE SA

58 jaar

Health Technology

Consumer Services

Actieve functies van Oliver Sol

Bedrijven	Functie	Begin	Einde
AC IMMUNE SA	Hoofd Techniek/Wetenschap/O&O	-	-
AC IMMUNE SA	Corporate Officer/Principal	-	-

Bedrijven	Functie	Begin	Einde
EUROBIO SCIENTIFIC	Hoofd Techniek/Wetenschap/O&O	-	-
EUROBIO SCIENTIFIC	Algemeen Adviseur	-	-
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Hoofd Techniek/Wetenschap/O&O	-	-

Internationaal

Frankrijk	4
Zwitserland	2

Operationeel

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
General Counsel	1

Sectoraal

Health Technology	4
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
AC IMMUNE SA	Health Technology
EUROBIO SCIENTIFIC	Health Technology

Bedrijven in privébezit	2
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Health Technology
Université de Paris XI Paris Sud	Consumer Services

Bedrijven in privébezit

Health Technology

Université de Paris XI Paris Sud

Consumer Services